Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the
Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosis: Study shows that ‘good inflammation’ promotes axon myelination
